Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral

Journal of Periodontology

Volumn 84, Issue 11, 2013, Pages 1546-1555

  Döri, Ferenc ^a   Arweiler, Nicole ^b   Huśzaŕ, Tamaś ^a   Gera, István ^a   Miron, Richard J ^c   Sculean, Anton ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bone transplantation; Clinical trial; Guided tissue regeneration; Periodontal; Platelet rich plasma; Wound healing

Indexed keywords

DISINFECTANT AGENT; EDETIC ACID; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN;

ADULT; ALVEOLAR BONE LOSS; ARTICLE; BONE TRANSPLANTATION; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GINGIVA DISEASE; HUMAN; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PHYSIOLOGY; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; SURGICAL FLAPS; THROMBOCYTE RICH PLASMA; TOOTH RADIOGRAPHY; TREATMENT OUTCOME; WOUND HEALING;

ADULT; ALVEOLAR BONE LOSS; BONE TRANSPLANTATION; CHRONIC PERIODONTITIS; DENTAL DISINFECTANTS; DENTAL ENAMEL PROTEINS; DENTAL SCALING; EDETIC ACID; FEMALE; FOLLOW-UP STUDIES; GINGIVAL RECESSION; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PLATELET-RICH PLASMA; RADIOGRAPHY, BITEWING; ROOT PLANING; SURGICAL FLAPS; TREATMENT OUTCOME; WOUND HEALING;

EID: 84888326333     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2013.120501     Document Type: Article

References (38)

1. Yamamoto S, Masuda H, Shibukawa Y, Yamada S. Combination of bovine-derived xenografts and enamel matrix derivative in the treatment of intrabony periodontal defects in dogs. Int J Periodontics Restorative Dent 2007;27:471-479.
2. Sculean A, Windisch P, Keglevich T, Chiantella GC, Gera I, Donos N. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovinederived xenograft. Int J Periodontics Restorative Dent 2003;23:47-55.
3. Sculean A, Chiantella GC, Arweiler NB, Becker J, Schwarz F, Stavropoulos A. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral. Int J Periodontics Restorative Dent 2008;28:153-161.
4. Trombelli L, Farina R. Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration. J Clin Periodontol 2008; 35(Suppl. 8)117-135.
5. Tu Y-K, Woolston A, Faggion CM JrJr. Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta-Analysis of randomized-controlled trials. J Clin Periodontol 2010;37:59-79.
6. Dori F, Arweiler N, Szantó E, Agics A, Gera I, Sculean A. Ten year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a beta-tricalcium phosphate. J Periodontol 2013;84:749-757.
7. Miron RJ, Bosshardt DD, Hedbom E, et al. Adsorption of enamel matrix proteins to a bovine-derived bone grafting material and its regulation of cell adhesion, proliferation, and differentiation. J Periodontol 2012;83:936-947.
8. Caffesse RG, Quinones CR. Polypeptide growth factors and attachment proteins in periodontal wound healing and regeneration. Periodontol 2000 1993;1:69-79.
9. Giannobile WV, Finkelman RD, Lynch SE. Comparison of canine and non-human primate animal models for periodontal regenerative therapy: Results following a single administration of PDGF/IGF-I. J Periodontol 1994;65:1158-1168.
10. Lynch SE, de Castilla GR, Williams RC, et al. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol 1991;62: 458-467.
11. Rutherford RB, Niekrash CE, Kennedy JE, Charette MF. Platelet-derived and insulin-like growth factors stimulate regeneration of periodontal attachment in monkeys. J Periodontal Res 1992;27:285-290.
12. Rutherford RB, Ryan ME, Kennedy JE, Tucker MM, Charette MF. Platelet-derived growth factor and dexamethasone combined with a collagen matrix induce regeneration of the periodontium in monkeys. J Clin Periodontol 1993;20:537-544.
13. Wang HL, Pappert TD, Castelli WA, Chiego DJ JrJr., Shyr Y, Smith BA. The effect of platelet-derived growth factor on the cellular response of the periodontium: An autoradiographic study on dogs. J Periodontol 1994;65:429-436.
14. Nevins M, Camelo M, Nevins ML, Schenk RK, Lynch SE. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. J Periodontol 2003; 74:1282-1292.
15. Ridgway HK, Mellonig JT, Cochran DL. Human histologic and clinical evaluation of recombinant human platelet-derived growth factor and betatricalcium phosphate for the treatment of periodontal intraosseous defects. Int J Periodontics Restorative Dent 2008;28:171-179.
16. Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997;68:1186-1193.
17. Nevins M, Giannobile WV, McGuire MK, et al. Plateletderived growth factor stimulates bone fill and rate of attachment level gain: Results of a large multicenter randomized controlled trial. J Periodontol 2005;76: 2205-2215.
18. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85:638-646.
19. Marx RE. Platelet-rich plasma: Evidence to support its use. J Oral Maxillofac Surg 2004;62:489-496.
20. Del Fabbro M, Bortolin M, Taschieri S, Weinstein R. Is platelet concentrate advantageous for the surgical treatment of periodontal diseases? A systematic review and meta-Analysis. J Periodontol 2011;82: 1100-1111.
21. Sculean A, Alessandri R, Miron R, Salvi GE, Bosshard DD. Enamel matrix proteins and periodontal wound healing and regeneration. Clin Adv Periodontics 2011;1:101-117.
22. Dori F, Nikolidakis D, Hú szá r T, Arweiler NB, Gera I, Sculean A. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral. J Clin Periodontol 2008;35:44-50.
23. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
24. Loe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol 1967;38:610-616.
25. Tonetti MS, Pini-Prato GP, Cortellini P. Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 1995;22:229-234.
26. Fleiss J. The Design and Analysis of Clinical Experiments. New York: John Wiley & Sons; 1986:120-148.
27. Appel TR, Potzsch B, Muller J, von Lindern JJ, Bergé SJ, Reich RH. Comparison of three different preparations of platelet concentrates for growth factor enrichment. Clin Oral Implants Res 2002;13: 522-528.
28. Blomlof JPS, Blomlof LB, Lindskog SF. Smear removal and collagen exposure after non-surgical root planing followed by etching with an EDTA gel preparation. J Periodontol 1996;67:841-845.
29. Sculean A, Schwarz F, Miliauskaite A, et al. Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: An 8-year follow-up split-mouth study. J Periodontol 2006;77: 1879-1886.
30. Sculean A, Schwarz F, Chiantella GC, Arweiler NB, Becker J. Nine-year results following treatment of intrabony periodontal defects with an enamel matrix derivative: Report of 26 cases. Int J Periodontics Restorative Dent 2007;27:221-229.
31. Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 2008;35:817-824.
32. Pietruska M, Pietruski J, Nagy K, Brecx M, Arweiler NB, Sculean A. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate. Clin Oral Investig 2012;16: 1191-1197.
33. Moder D, Taubenhansl F, Hiller KA, Schmalz G, Christgau M. Influence of autogenous platelet concentrate on combined GTR/graft therapy in intrabony defects: A 7-year follow-up of a randomized prospective clinical split-mouth study. J Clin Periodontol 2012;39:457-465.
34. Weibrich G, Kleis WK, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: Curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants 2002;17:184-190.
35. Miron RJ, Bosshardt DD, Zhang Y, Buser D, Sculean A. Gene array of primary human osteoblasts exposed to enamel matrix derivative in combination with a natural bone mineral. Clin Oral Investig 2013;17:405-410.
36. Miron RJ, Hedbom E, Ruggiero S, et al. Premature osteoblast clustering by enamel matrix proteins induces osteoblast differentiation through up-regulation of connexin 43 and N-cadherin. PLoS ONE 2011;6: e23375.
37. Gunsolley JC, Elswick RK, Davenport JM. Equivalence and superiority testing in regeneration clinical trials. J Periodontol 1998;69:521-527.
38. Matuliene G, Pjetursson BE, Salvi GE, et al. Influence of residual pockets on progression of periodontitis and tooth loss: Results after 11 years of maintenance. J Clin Periodontol 2008;35:685-695.